TRELLUS HEALTH LS -0006 Market Cap ($215.06K)
Market Cap & Net Worth: TRELLUS HEALTH LS -0006 (85Q)
TRELLUS HEALTH LS -0006 market cap. TRELLUS HEALTH LS -0006 (F:85Q) has a market capitalization of $215.06K (€183.95K) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #31349 globally and #2782 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying TRELLUS HEALTH LS -0006's stock price €0.00 by its total outstanding shares 430119153 (430.12 Million). Also see cash flow conversion of TRELLUS HEALTH LS -0006 for how efficiently the company converts equity into cash flow.
TRELLUS HEALTH LS -0006 Market Cap History (2021–2026)
TRELLUS HEALTH LS -0006 market cap history from 2021 to 2026. Data shows change from $247.40 Million to $251.43K (-76.66% CAGR). Check TRELLUS HEALTH LS -0006 stock price for real-time trading data and today's change.
TRELLUS HEALTH LS -0006 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how TRELLUS HEALTH LS -0006's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of TRELLUS HEALTH LS -0006 to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
26.47x
TRELLUS HEALTH LS -0006's market cap is 26.47 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $247.40 Million | $25.00K | -$5.90 Million | 9896.18x | N/A |
| 2022 | $28.66 Million | $18.00K | -$8.81 Million | 1592.37x | N/A |
| 2023 | $12.32 Million | $19.00K | -$6.34 Million | 648.42x | N/A |
| 2024 | $3.02 Million | $114.00K | -$7.78 Million | 26.47x | N/A |
Competitor Companies of 85Q by Market Capitalization
Companies near TRELLUS HEALTH LS -0006 in the global market cap rankings as of November 3, 2026. Also see TRELLUS HEALTH LS -0006 balance sheet assets for a full breakdown of the balance sheet.
Key companies related to TRELLUS HEALTH LS -0006 by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #719 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1627 globally with a market cap of $14.50 Billion USD ( AU$20.50 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2005 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2067 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #719 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $312.96 |
| #1627 | Pro Medicus Ltd | AU:PME | $14.50 Billion | AU$196.20 |
| #2005 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $72.22 |
| #2067 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $66.89 |
Market Capitalization of TRELLUS HEALTH LS -0006 (2021–2026)
Market capitalization of TRELLUS HEALTH LS -0006 from 2021 to today. Between 2021 and today, TRELLUS HEALTH LS -0006's market cap moved from $247.40 Million to $ 251.43K, with a yearly change of -76.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €251.43K | -88.89% |
| 2025 | €2.26 Million | -25.00% |
| 2024 | €3.02 Million | -75.51% |
| 2023 | €12.32 Million | -57.02% |
| 2022 | €28.66 Million | -88.41% |
| 2021 | €247.40 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 2nd, 2026 the market cap of TRELLUS HEALTH LS -0006 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $215.06K USD |
| MoneyControl | $215.06K USD |
| MarketWatch | $215.06K USD |
| marketcap.company | $215.06K USD |
| Reuters | $215.06K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About TRELLUS HEALTH LS -0006
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease, including Crohn's Disease and ulcerative colitis. The company was incorporated… Read more